Process for making salts of N-hydroxy3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]a mino]methyl]phenyl]-2E-2-propenamide

Details for Australian Patent Application No. 2007257882 (hide)

Owner Novartis AG

Inventors Parker, David John; Bajwa, Joginder S.; Slade, Joel

Agent Davies Collison Cave

Pub. Number AU-B-2007257882

PCT Pub. Number WO2007/146717

Priority 60/853,259 20.10.06 US; 60/804,529 12.06.06 US

Filing date 7 June 2007

Wipo publication date 21 December 2007

Acceptance publication date 8 September 2011

International Classifications

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/146717 Priority application(s): WO2007/146717

8 September 2011 Application Accepted

  Published as AU-B-2007257882

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007257883-Process for making N-hydroxy3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]a mino] methyl]phenyl]-2E-2-propenamide and starting materials therefor

2007257881-Polymorphs of N-hydroxy3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]a mino]methyl]phenyl]-2E-2-propenamide